Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.53 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CPA1 | P15085 | 2/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPA3 | P15088 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29903902 | 1.00 | L3MBTL1 (0.61) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL377175 | 1.00 | L3MBTL1 (0.61) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL146867 | 1.00 | L3MBTL1 (0.61) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL23782080 | 0.98 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL6739142 | 0.98 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL11137284 | 0.91 | L3MBTL1 (0.71) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL3274728 | 0.89 | ALDH1A1 (0.51) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL28306756 | 0.88 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL10717750 | 0.87 | MEN1 (0.54) | L3MBTL1ALDH1A1GAAPOLBTDP1 | |
| SCHEMBL9736992 | 0.86 | GABBR2 (0.53) | L3MBTL1ALDH1A1GAAPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119351080-A | Chiral identification material and preparation method and application thereof | 中国科学院化学研究所 | 2025-01-24 | — | — | CN | claimed |
| EP-0828767-B1 | MOLECULARLY IMPRINTED BEADED POLYMERS AND STABILIZED SUSPENSION POLYMERIZATION OF THE SAME IN PERFLUOROCARBON LIQUIDS | IGEN INC (US) | 2003-07-30 | — | — | EP | claimed |
| US-5872198-A | MOLECULARLY IMPRINTED POLYMER SUPPORTS CAPABLE OF SEPARATING OR RESOLVING AMINO-ACIDS, AMINO-ACID DERIVATIVES, PHARMACEUTICAL COMPOUNDS AND POLYSACCHARIDES | MOSBACH KLAUS (SE) | 1999-02-16 | — | — | US | claimed |
| EP-0828767-A1 | MOLECULARLY IMPRINTED BEADED POLYMERS AND STABILIZED SUSPENSION POLYMERIZATION OF THE SAME IN PERFLUOROCARBON LIQUIDS | IGEN, INC. (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037527-A1 | MOLECULARLY IMPRINTED BEADED POLYMERS AND STABILIZED SUSPENSION POLYMERIZATION OF THE SAME IN PERFLUOROCARBON LIQUIDS | IGEN, INC. (US) | 1996-11-28 | — | — | WO | claimed |
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | KURA ONCOLOGY INC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4720073-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | Kura Oncology, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12466835-B1 | Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same | KURA ONCOLOGY, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| US-12384757-B2 | Methods of synthesizing substituted pyridinone-pyridinyl compounds | ACLARIS THERAPEUTICS, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250195495-A1 | RNA Virus Inhibitor Compounds and Uses Thereof | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2025-06-19 | — | — | US | disclosed |
| CN-119351080-A | Chiral identification material and preparation method and application thereof | 中国科学院化学研究所 | 2025-01-24 | — | — | CN | disclosed |
| US-12186309-B2 | RNA virus inhibitor compounds and uses thereof | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2025-01-07 | — | — | US | disclosed |
| WO-1999064044-A1 | NOVEL THERAPEUTIC AGENTS THAT MODULATE 5-HT RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| US-5959050-A | COMPRISING SPHERICAL, UNIFORMLY SHAPED, AND NON-AGGREGATED PARTICLES FORMED BY SUSPENSION POLYMERIZATION OF TWO DISTINCT ACRYLIC MONOMERS IN THE PRESENCE OF IMPRINT MOLECULE, LIQUID FLUROCARBON, FLUOROCARBON POLYMER | MOSBACH, KLAUS (CH) | 1999-09-28 | — | — | US | disclosed |
| US-5872198-A | MOLECULARLY IMPRINTED POLYMER SUPPORTS CAPABLE OF SEPARATING OR RESOLVING AMINO-ACIDS, AMINO-ACID DERIVATIVES, PHARMACEUTICAL COMPOUNDS AND POLYSACCHARIDES | MOSBACH KLAUS (SE) | 1999-02-16 | — | — | US | disclosed |
| US-5821311-A | Stabilizers, polymers, and emulsions useful for molecular imprinting technology | MOSBACH KLAUS (CH) | 1998-10-13 | — | — | US | disclosed |
| EP-0828767-A1 | MOLECULARLY IMPRINTED BEADED POLYMERS AND STABILIZED SUSPENSION POLYMERIZATION OF THE SAME IN PERFLUOROCARBON LIQUIDS | IGEN, INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996037527-A1 | MOLECULARLY IMPRINTED BEADED POLYMERS AND STABILIZED SUSPENSION POLYMERIZATION OF THE SAME IN PERFLUOROCARBON LIQUIDS | IGEN, INC. (US) | 1996-11-28 | — | — | WO | disclosed |
| WO-1995007260-A1 | TETRAHYDROISOQUINOLINES AS ALPHA-2 ANTAGONISTS AND BIOGENIC AMINE UPTAKE INHIBITORS | ABBOTT LABORATORIES (US) | 1995-03-16 | — | — | WO | disclosed |
| US-5389638-A | Nervous system disorders | ABBOTT LABORATORIES (US) | 1995-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | FDPS, PCTP, MTTP | L3MBTL1 2185/4885ALDH1A1 3778/4885GAA 2995/4885 |
| US-12466835-B1 | Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same | FNTA, SF3B1, SF3A1 | L3MBTL1 1940/4885ALDH1A1 3388/4885GAA 3779/4885 |
| US-12384757-B2 | Methods of synthesizing substituted pyridinone-pyridinyl compounds | PIR, PUM1, ZRANB2 | L3MBTL1 4649/4885ALDH1A1 873/4885GAA 3570/4885 |
| US-20250195495-A1 | RNA Virus Inhibitor Compounds and Uses Thereof | NSUN3, EIF2AK2, NSUN2 | L3MBTL1 747/4885ALDH1A1 3057/4885GAA 351/4885 |
| US-12186309-B2 | RNA virus inhibitor compounds and uses thereof | NSUN3, EIF2AK2, NSUN2 | L3MBTL1 747/4885ALDH1A1 3057/4885GAA 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.